The European Medicines Agency EMA wants to announce a decision this Thursday on the further use of AstraZeneca's corona vaccine.
The news ticker.
Coronavirus pandemic
:
AstraZeneca's corona vaccine
is in focus because of thrombosis cases.
The European Medicines Agency (EMA) is examining the concerns and is expected to come to a recommendation for the EU member states on Thursday (March 18).
This
news ticker for AstraZeneca
is updated regularly.
Update from March 18, 12.15 p.m.:
More and more points about the EMA decision on vaccinations with AstraZeneca are coming out.
And the details are tough.
As the head of the North Rhine National Association of Statutory Health Insurance Physicians, Frank Bergmann,
explained
to the
Rheinische Post
, there could be a connection between smoking, the contraceptive pill for women as a contraceptive and vaccinations.
It therefore does not rule out restrictions such as vaccinations with AstraZeneca "for example only for certain age groups or, for example, without using the pill at the same time".
Corona vaccine from AstraZeneca: Thromboses after vaccinations are examined by the EMA
First report from March 18:
Munich / Amsterdam - There were plenty of discussions.
Once again in the coronavirus pandemic in Germany.
This time when Federal Health Minister Jens Spahn (CDU) announced the temporary vaccination ban with AstraZeneca in the Federal Republic due to concerns.
Previously, there had been seven thrombosis cases after vaccinations with the active ingredient from the Swedish-British manufacturer - including social uncertainty.
Corona vaccinations with AstraZeneca: EMA registers fewer thrombosis cases "than expected"
This Thursday (March 18) the European Medicines Agency EMA wants to make its recommendation for the member states of the European Union (EU).
Even in advance, the first findings leaked through after checking the previously available data on the vaccinations with AstraZeneca.
As the
picture
(behind a payment barrier) reports, 15 cases (eleven women, four men) were noted in which vaccinated people had a so-called deep vein thrombosis.
However, there is no discernible trend.
Even more: The thrombosis cases registered so far are "significantly lower than the expected number of events".
So it suggests a recommendation to continue vaccinating with the agent.
Follow all
developments regarding the AstraZeneca vaccinations here in the news ticker.
(pm)
* Merkur.de is an offer from IPPEN.MEDIA